Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors

出版年份 2014 全文链接

标题

作者

关键词

Phase I Trials, Kinase inhibitors, Pharmacokinetics and pharmacodynamics

出版物

Volume 33, Issue 2, Pages 349-356

出版商

Springer Nature

发表日期

2014-12-04

DOI

10.1007/s10637-014-0191-5

参考文献

查看 5 条相关文献

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started